COMMUNIQUÉS West-GlobeNewswire

TerrAscend to Host Second Quarter 2024 Earnings Conference Call
10/07/2024
TORONTO, July 10, 2024 (GLOBE NEWSWIRE) -- TerrAscend Corp. ("TerrAscend" or the "Company") (TSX: TSND) (OTCQX: TSNDF) , a leading North American cannabis company, today announced that it will host a scheduled [...]
Context Therapeutics Acquires Phase 1-ready T cell Engager CT-95
10/07/2024
CT-95 is a potentially first-in-class mesothelin x CD3 bispecific antibody Acquisition expands Context pipeline with second clinical-stage T cell engager for solid tumors PHILADELPHIA, July 10, 2024 (GLOBE NEWSWIRE) -- [...]
ExactCare and Tabula Rasa HealthCare Rebrand Combined Organization as AnewHealth
10/07/2024
AnewHealth provides transformative pharmacy solutions that elevate care and help providers and payers overcome the unique challenges of caring for the most at-risk patients in healthcare CLEVELAND, OH and MOORESTOWN, NJ [...]
Theratechnologies Reports Financial Results and Announces Positive Net Income for Second Quarter 2024
10/07/2024
Q2 revenue of $22 million represents +25% growth year-over-year Positive net income of $1 million realized with Adjusted EBITDA 1 of $5.5 million Fiscal 2024 revenue guidance confirmed between $87 and $90 million and an [...]
Theratechnologies présente ses résultats financiers et annonce un bénéfice net positif pour le deuxième trimestre de l’exercice 2024
10/07/2024
Revenus de 22 millions de dollars au deuxième trimestre , en hausse de 25 % d’un exercice à l’autre Réalisation d’un bénéfice net ajusté de 1 million de dollars et d’un BAIIA ajusté 1 de 5,5 millions de dollars [...]
Longeveron® Announces U.S. FDA Grants Lomecel-B™ Regenerative Medicine Advanced Therapy (RMAT) Designation for the Treatment of Mild Alzheimer’s Disease
10/07/2024
- Lomecel-B™ appears to be the first cellular therapeutic candidate to receive RMAT designation for Alzheimer’s Disease MIAMI, July 10, 2024 (GLOBE NEWSWIRE) -- Longeveron Inc. (NASDAQ: LGVN), a clinical stage [...]
Aurora Spine Corporation to Attend Sixth Annual American Society of Pain & Neuroscience Conference
10/07/2024
CARLSBAD, Calif., July 10, 2024 (GLOBE NEWSWIRE) -- Aurora Spine Corporation (“Aurora Spine” or the “Company”) (TSXV: ASG) (OTCQB: ASAPF), a designer and manufacturer of innovative medical devices that improve spinal [...]
BioStem Receives Institutional Review Board (IRB) Approval to Advance a Clinical Study Evaluating AmnioWrap2™ in Diabetic Foot Ulcers
10/07/2024
POMPANO BEACH, Fla., July 10, 2024 (GLOBE NEWSWIRE) -- BioStem Technologies Inc. (OTC: BSEM), a leading regenerative medicine company focused on the development, manufacture, and commercialization of placental-derived [...]
Aesthetic Medical International Holdings Group Ltd. Announces the Commencement of OTCQX Trading
10/07/2024
SHENZHEN, China, July 10, 2024 (GLOBE NEWSWIRE) -- Aesthetic Medical International Holdings Group Limited (OTCQX: PAIYY) (the “Company” or “AIH”), a leading provider of aesthetic medical services in China, is pleased to [...]
Quell Therapeutics Appoints Experienced Biopharma Leader Luke Beshar as Independent Chair of its Board of Directors
10/07/2024
Quell Therapeutics Appoints Experienced Biopharma Leader Luke Beshar as Independent Chair of its Board of Directors London, UK – July 10, 2024 – Quell Therapeutics Ltd (“Quell”), a world leader in developing engineered [...]
RTI Surgical appoints Chad Croasdale as Chief Commercial Officer
10/07/2024
RTI Surgical appoints Chad Croasdale as Chief Commercial Officer ALACHUA, Fla., July 10, 2024 ; RTI Surgical ("RTI" or "the Company"), a leading CDMO pushing the boundaries of innovation and tissue engineering to meet [...]
Gritstone bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
10/07/2024
EMERYVILLE, Calif., July 10, 2024 (GLOBE NEWSWIRE) -- Gritstone bio, Inc. (Nasdaq: GRTS), a clinical-stage biotechnology company that aims to develop the world’s most potent vaccines, today announced that the [...]
FDA Approves Arcutis’ ZORYVE® (roflumilast) Cream 0.15% for the Treatment of Atopic Dermatitis in Adults and Children Down to 6 Years of Age
09/07/2024
ZORYVE cream provides rapid relief, with efficacy, safety, and tolerability demonstrated up to 56 weeks of treatment ZORYVE cream rapidly and significantly reduces itch, the most bothersome symptom of atopic dermatitis [...]
Certara to Acquire Chemaxon to Strengthen Drug Discovery Software Portfolio
09/07/2024
Combined organization brings broader predictive capabilities to drug discovery at scale Reiterates full year 2024 guidance RADNOR, Pa., July 09, 2024 (GLOBE NEWSWIRE) -- Certara, Inc. (Nasdaq: CERT), a global leader in [...]
Assertio Holdings, Inc. Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
09/07/2024
LAKE FOREST, Ill., July 09, 2024 (GLOBE NEWSWIRE) -- Assertio Holdings, Inc. (“Assertio” or the “Company”) (NASDAQ: ASRT), a pharmaceutical company with comprehensive commercial capabilities offering differentiated [...]
AMN Healthcare Appoints Jim Hinton to Board of Directors
09/07/2024
DALLAS, July 09, 2024 (GLOBE NEWSWIRE) -- AMN Healthcare (NYSE: AMN) the leader in total talent solutions has appointed healthcare veteran Jim Hinton to the board of directors effective July 22. He brings an extensive [...]
Voting Rights and Shares Capital of the Company
09/07/2024
In accordance with Articles L.233-8 II of the French Commercial Code and 223-16 of the General Regulation of the French Financial Markets Authority (Autorité des Marchés Financiers) PARIS, July 09, 2024 (GLOBE NEWSWIRE [...]
Information mensuelle relative au nombre total de droits de vote et d’actions composant le capital social
09/07/2024
Conformément aux articles L.233-8 II du Code de commerce et 223-16 du Règlement Général de l’Autorité des Marchés Financiers PARIS, 09 juill. 2024 (GLOBE NEWSWIRE) -- Place de cotation : Euronext Paris / Nasdaq Euronext [...]
GENFIT: Half-Year Report of Liquidity Contract with Crédit Industriel et Commercial
09/07/2024
Lille (France), Cambridge (Massachusetts, United States), Zurich (Switzerland) July 9, 2024 – GENFIT (Nasdaq and Euronext: GNFT) , a late-stage biopharmaceutical company dedicated to improving the lives of patients with [...]

Pages